Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("TOLMACHEV, Vladimir")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 46

  • Page / 2
Export

Selection :

  • and

Issues of environmental impacts of karst in standards on construction in RussiaTOLMACHEV, Vladimir.Environmental geology (Berlin). 2007, Vol 51, Num 5, pp 787-790, issn 0943-0105, 4 p.Article

Imaging agents for in vivo molecular profiling of disseminated prostate cancer - targeting EGFR receptors in prostate cancer: Comparison of cellular processing of [111In]-labeled affibody molecule ZEGFR:2377 and cetuximabMALMBERG, Jennie; TOLMACHEV, Vladimir; ORLOVA, Anna et al.International journal of oncology. 2011, Vol 38, Num 4, pp 1137-1143, issn 1019-6439, 7 p.Article

Feasibility of palladium-catalyzed isotopic exchange between sodium [12I]I and 2-iodo-para-carboraneERIKSSON, Ludvig; TOLMACHEV, Vladimir; SJÖBERG, Stefan et al.Journal of labelled compounds & radiopharmaceuticals. 2003, Vol 46, Num 7, pp 623-631, issn 0362-4803, 9 p.Article

Liver uptake of radiolabeled targeting proteins and peptides: considerations for targeting peptide conjugate designSEYED JALAL HOSSEINIMEHR; TOLMACHEV, Vladimir; ORLOVA, Anna et al.Drug discovery today. 2012, Vol 17, Num 21-22, pp 1224-1232, issn 1359-6446, 9 p.Article

Production, PET performance and dosimetric considerations of 134Ce/134La, an Auger electron and positron-emitting generator for radionuclide therapyLUBBERINK, Mark; LUNDQVIST, Hans; TOLMACHEV, Vladimir et al.Physics in medicine & biology (Print). 2002, Vol 47, Num 4, pp 615-629, issn 0031-9155Article

Kit formulation for 99mTc-labeling of recombinant anti-HER2 Affibody molecules with a C-terminally engineered cysteineAHLGREN, Sara; ANDERSSON, Kristofer; TOLMACHEV, Vladimir et al.Nuclear medicine and biology. 2010, Vol 37, Num 5, pp 539-546, issn 0969-8051, 8 p.Article

Effect of cetuximab in combination with alpha-radioimmunotherapy in cultured squamous cell carcinomasNESTOR, Marika; SUNDSTRÖM, Magnus; ANNIKO, Matti et al.Nuclear medicine and biology. 2011, Vol 38, Num 1, pp 103-112, issn 0969-8051, 10 p.Article

Positron emission tomography of experimental melanoma with [76Br]5-bromo-2-thiouracilMARS, Ulla; TOLMACHEV, Vladimir; SUNDIN, Anders et al.Nuclear medicine and biology. 2000, Vol 27, Num 8, pp 845-849, issn 0969-8051Article

Treatment of cultured glioma cells with the EGFR-TKI gefitinib (Iressa, zd1839) increases the uptake of astatinated EGF despite the absence of gefitinib-mediated growth inhibitionSUNDBERG, Asa Liljegren; ALMQVIST, Ylva; TOLMACHEV, Vladimir et al.European journal of nuclear medecine and molecular imaging Print. 2003, Vol 30, Num 5, pp 727-729, issn 1619-7070, 3 p.Article

Optimized indirect 76Br-bromination of antibodies using N-succinimidyl para-[76Br]bromobenzoate for radioimmuno PETHÖGLUND, Johanna; TOLMACHEV, Vladimir; ORLOVA, Anna et al.Nuclear medicine and biology. 2000, Vol 27, Num 8, pp 837-843, issn 0969-8051Article

Comparative biodistribution of imaging agents for in vivo molecular profiling of disseminated prostate cancer in mice bearing prostate cancer xenografts: focus on 111In- and 125I-labeled anti-HER2 humanized monoclonal trastuzumab and ABY-025 AffibodyMALMBERG, Jennie; SANDSTRÖM, Mattias; WESTER, Kenneth et al.Nuclear medicine and biology. 2011, Vol 38, Num 8, pp 1093-1102, issn 0969-8051, 10 p.Article

Cellular processing in the SW1222 cell line of mAb A33 directly and indirectly radiohalogenatedHÖGLUND, Johanna; ORLOVA, Anna; SUNDIN, Anders et al.Oncology reports. 2006, Vol 16, Num 1, pp 159-163, issn 1021-335X, 5 p.Article

Synthesis and radioiodination of 7-(3'-ammoniopropyl)-7,8-dicarba-nido-undecaborate(-1), (ANC)GHIRMAI, Senait; MALMQUIST, Jonas; LUNDQUIST, Hans et al.Journal of labelled compounds & radiopharmaceuticals. 2004, Vol 47, Num 9, pp 557-569, issn 0362-4803, 13 p.Article

Synthesis and radioiodination of some 9-aminoacridine derivatives for potential use in radionuclide therapyGHIRMAI, Senait; MUME, Eskender; LUNDQVIST, Hans et al.Journal of labelled compounds & radiopharmaceuticals. 2005, Vol 48, Num 12, pp 855-871, issn 0362-4803, 17 p.Article

Radiobromination of closo-carboranes using palladium-catalyzed halogen exchangeWINBERG, Karl Johan; MUME, Eskender; TOLMACHEV, Vladimir et al.Journal of labelled compounds & radiopharmaceuticals. 2005, Vol 48, Num 3, pp 195-202, issn 0362-4803, 8 p.Article

[177Lu]Pertuzumab : Experimental therapy of HER-2-expressing xenograftsPERSSON, Mikael; GEDDA, Lars; LUNDQVIST, Hans et al.Cancer research (Baltimore). 2007, Vol 67, Num 1, pp 326-331, issn 0008-5472, 6 p.Article

Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific affibody moleculeTOLMACHEV, Vladimir; ORLOVA, Anna; WENNBORG, Anders et al.Cancer research (Baltimore). 2007, Vol 67, Num 6, pp 2773-2782, issn 0008-5472, 10 p.Article

Radio-iodination of monoclonal antibody using potassium [125I]-(4-isothiocyanatobenzylammonio)-iododecahydro-closo-dodecaborate (Iodo-DABI)ORLOVA, Anna; BRUSKIN, Alexander; SIVAEV, Igor et al.Anticancer research. 2006, Vol 26, Num 2A, pp 1217-1223, issn 0250-7005, 7 p.Article

Combined effect of gefitinib ('Iressa', ZD1839) and targeted radiotherapy with 211At-EGFSUNDBERG, Asa Liljegren; ALMQVIST, Ylva; ORLOVA, Anna et al.European journal of nuclear medecine and molecular imaging Print. 2003, Vol 30, Num 10, pp 1348-1356, issn 1619-7070, 9 p.Article

Influence of an aliphatic linker between DOTA and synthetic ZHER2:342 Affibody molecule on targeting properties of the 111 In-labeled conjugateTOLMACHEV, Vladimir; FELDWISCH, Joachim; LINDBORG, Malin et al.Nuclear medicine and biology. 2011, Vol 38, Num 5, pp 697-706, issn 0969-8051, 10 p.Article

Tumor imaging using a picomolar affinity HER2 binding affibody moleculeORLOVA, Anna; MAGNUSSON, Mikaela; NILSSON, Fredrik Y et al.Cancer research (Baltimore). 2006, Vol 66, Num 8, pp 4339-4348, issn 0008-5472, 10 p.Article

[99mTc] HYNIC-hEGF, a potential agent for imaging of EGF receptors in vivo: Preparation and pre-clinical evaluationMOHAMMAD HOSSEIN BABAEI; ALMQVIST, Ylva; ORLOVA, Anna et al.Oncology reports. 2005, Vol 13, Num 6, pp 1169-1175, issn 1021-335X, 7 p.Article

Targeting of a head and neck squamous cell carcinoma xenograft model using the chimeric monoclonal antibody U36 radioiodinated with a closo-dodecaborate-containing linkerJUNPING CHENG; PERSSON, Mikael; TOLMACHEV, Vladimir et al.Acta oto-laryngologica. 2004, Vol 124, Num 9, pp 1078-1085, issn 0001-6489, 8 p.Article

Targeting against epidermal growth factor receptors. cellular processing of astatinated EGF after binding to cultured carcinoma cellsORLOVA, Anna; SJÖSTRÖM, Anna; LEBEDA, Ondrej et al.Anticancer research. 2004, Vol 24, Num 6, pp 4035-4041, issn 0250-7005, 7 p.Article

Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomographyBESHARA, Soheir; SÖRENSEN, Jens; LUBBERINK, Mark et al.British journal of haematology. 2003, Vol 120, Num 5, pp 853-859, issn 0007-1048, 7 p.Article

  • Page / 2